주식/증권
➡️ 중립
Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference
요약
LANGHORNE, Pa., May 11, 2026--Savara Inc. (Nasdaq: SVRA) (the "Company"), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will participate in a fireside chat at the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference on Tuesday, May 19th at 10:00am ET in New York, NY at the NASDAQ headquarters.